论文部分内容阅读
目的:探讨慢性肾小球肾炎采取肾复康胶囊联合注射阿魏酸钠治疗的临床效果。方法:选取茂名市电白区人民医院2015年1月至2016年1月就诊并同意参与本次研究的慢性肾小球肾炎患者82例,随机分为两组,对照组41例,单纯给予阿魏酸钠静脉滴注治疗,观察组41例,给予肾复康胶囊联合阿魏酸钠治疗,连续治疗1个月后,对比两组患者的用药效果,并测定两组患者血尿素氮、血肌酐、24 h尿蛋白量、尿β2-微球蛋白、红细胞等水平变化。结果:观察组治疗后血尿素氮、血肌酐等肾功能检查优于对照组,差异具有统计学意义(P<0.05);观察组治疗后24 h尿蛋白量、尿β2-微球蛋白、红细胞等尿液检查优于对照组,差异具有统计学意义(P<0.05);观察组治疗总有效率明显较对照组高,差异具有统计学意义(P<0.05);且无严重不良反应发生。结论:慢性肾小球肾炎患者采取肾复康胶囊联合阿魏酸钠治疗的疗效较好,能改善患者临床症状。
Objective: To investigate the clinical effect of taking Shenfukang capsule combined with sodium ferulate in treating chronic glomerulonephritis. Methods: Eighty-two patients with chronic glomerulonephritis were selected from People’s Hospital of Dianbai District of Maoming City from January 2015 to January 2016 and were randomly divided into two groups. The control group consisted of 41 cases, Weidi sodium intravenous infusion of the observation group of 41 cases, given Shenfukang capsule combined with sodium ferulate, after 1 month of continuous treatment, the two groups were compared the effect of medication, and the two groups of patients with blood urea nitrogen, blood Creatinine, 24 h urinary protein, urinary β2-microglobulin, red blood cells and other levels. Results: The renal function tests of blood urea nitrogen and serum creatinine in the observation group were better than those in the control group after treatment (P <0.05). Urine protein, urine β2-microglobulin, red blood cells The urine test was superior to the control group (P <0.05). The total effective rate of the observation group was significantly higher than that of the control group (P <0.05). No serious adverse reactions occurred. Conclusion: The treatment of chronic glomerulonephritis patients taking Shenfukang capsule combined with sodium ferulate is effective and can improve the clinical symptoms.